Celiac Disease Foundation is pleased to announce the release of Gluten-Free Marketplace 2.0, our completely updated, one-stop destination to search for all of your favorite gluten-free products, services, companies, and recipes. The Gluten-Free Marketplace is available at celiac.org/marketplace and as an app for iPhone and Android. Marketplace 2.0 showcases products and services from companies that […]
Attend the National Research Symposium & Gluten-Free EXPO June 3-4, 2017 Register Now
We fight to improve the lives of all people affected by celiac disease and non-celiac wheat sensitivity now
The March 19, 2017 Summit brought patients and consumer advocates together with guideline developers, methodologists, and other stakeholders in the clinical guideline enterprise for the purpose of constructive dialogue and initiation of durable relationships between them.
At the March 9 and 10, 2017 Genetic Alliance Conference, Celiac Disease Foundation worked to determine best strategies to help grow our iCureCeliac® patient registry, and to encourage patients and their family members to engage in the research process to influence the future of celiac disease research toward treatments and a cure.
At the March 5 and 6, 2017 Digestive Disease National Coalition Public Policy Forum, Celiac Disease Foundation, together with representatives from digestive disease organizations across the United States, developed common agendas to influence healthcare policy.
Celiac Disease Foundation, in partnership with the University of Southern California (USC) Keck School of Medicine, and CDF Board member Dr. Michael S. Karp, Chief of the Division of Geriatric, Hospital, Palliative and General Internal Medicine, is proud to launch a pioneering celiac disease training program for Internal Medicine residents. This program is made possible […]
ImmusanT, a Cambridge, MA-based biotechnology company, has announced that Nexvax2®, an immunotherapy drug designed to protect celiac disease patients from gluten exposure, has successfully completed a Phase 1b clinical trial and is advancing to a Phase 2 trial. Currently, strict, lifetime adherence to a gluten-free diet is the only disease management protocol for celiac disease […]